IDSA Recommends Advisory Committee To Prioritize Antimicrobial R&D
This article was originally published in The Pink Sheet Daily
Executive Summary
The Infectious Disease Society of America recommends the creation of an advisory committee to prioritize antimicrobial R&D
You may also be interested in...
Antimicrobial Drug Approvals Should Include Pathogen-Specific Indications
FDA should be granted authority to approve antimicrobial drugs based on the pathogens they target rather than infection types.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles